Author:
Grzegorzewicz Anna E,Pham Ha,Gundi Vijay A K B,Scherman Michael S,North Elton J,Hess Tamara,Jones Victoria,Gruppo Veronica,Born Sarah E M,Korduláková Jana,Chavadi Sivagami Sundaram,Morisseau Christophe,Lenaerts Anne J,Lee Richard E,McNeil Michael R,Jackson Mary
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference49 articles.
1. World Health Organization. Global Tuberculosis Control – Epidemiology, Strategy, Financing (World Health Organization, 2009).
2. Global Alliance for TB Drug Development. Scientific blueprint for TB drug development. Tuberculosis (Edinb.) 81, 1–52 (2001).
3. Center for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000–2004. MMWR Morb. Mortal. Wkly. Rep. 55, 301–305 (2006).
4. Schroeder, E.K., de Souza, O.N., Santos, D.S., Blanchard, J.S. & Basso, L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol. 3, 197–225 (2002).
5. Barry, C.E., Crick, D.C. & McNeil, M.R. Targeting the formation of the cell wall core of Mycobacterium tuberculosis. Infect. Disord. Drug Targets 7, 182–202 (2007).
Cited by
374 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献